動物用藥品市場規模、佔有率和成長分析：按產品類型、動物種類、給藥途徑、應用、分銷管道、最終用戶和地區分類－2026年至2033年產業預測

2024 年全球動物用藥品市場價值 475 億美元，預計到 2025 年將成長至 509.2 億美元，到 2033 年將成長至 888.1 億美元，在預測期（2026-2033 年）內複合年成長率為 7.2%。

全球動物用藥品市場的主要驅動力是不斷成長的動物保健產品需求，而寵物數量的增加、畜牧業的擴張以及人們健康意識的提高等成長要素又進一步推動了這一需求。該市場涵蓋伴侶動物和生產動物所需的基本藥品、疫苗、驅蟲藥和生物製藥，對食品安全和通用感染疾病的控制有重大影響。標靶治療（例如單株抗體）和生物製藥的進步已經改變了動物照護方式。抗菌素抗藥性和嚴格的法規結構正在影響市場動態，因此需要疫苗和益生菌等替代策略。此外，人工智慧的進步正在透過利用數據驅動的洞察力進行標靶識別和藥物最佳化，從而革新藥物發現，最終縮短研發週期並提高跨物種轉化應用的相關性。這種技術主導的變革正在獸醫領域創造新的商機。

全球動物用藥品市場的成長要素

全球動物用藥品市場的主要促進因素之一是通用感染疾病的增加以及寵物飼主和畜牧養殖戶對動物健康的日益重視。除了寵物產業的成長外，預防醫學的日益普及也顯著影響動物用藥品的需求。此外，動物用藥品的進步，尤其是更有效的治療方法和更安全的配方，進一步推動了市場擴張。隨著大眾對動物性疾病的擔憂日益加劇，對創新動物用藥品的需求也變得愈發重要，最終將推動市場朝著更完善的動物保健解決方案發展。

全球動物用藥品市場的限制因素

全球動物用藥品市場的主要限制因素之一是嚴格的法規環境，對動物用藥品的核准和使用有嚴格的規定。監管機構要求提供包括臨床試驗在內的大量研究數據，以確保動物用藥品的安全性和有效性。這種嚴格的核准流程會導致研發成本增加和上市時間延長，可能阻礙創新。此外，不同地區的監管差異也使市場格局更加複雜，企業難以遵守，並影響其有效進入不同市場的能力。

全球動物用藥品市場趨勢

全球動物用藥品市場正經歷一場變革，而數位化診斷和遠端醫療的普及正是推動這項變革的動力。遠距醫療和先進的床邊診斷工具正在革新臨床工作流程，加快決策速度，並加強病患監測。人工智慧技術和雲端服務正在將獸醫服務的覆蓋範圍擴展到傳統獸醫診所之外。這些創新以及臨床管理系統的整合正在創造新的收入來源和服務模式，並提升獸醫服務的便利性和應對力。建立全面的解決方案需要製造商和服務供應商之間的合作，這要求對臨床醫生培訓和資料互通性進行大量投資。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢
• 價值鏈分析
• 案例研究
• 技術評估
• 客戶和採購標準分析
• 管道分析
• 疾病流行病學

全球動物用藥品市場規模：依產品類型分類

• 抗感染藥物
• 殺蟲劑
• 抗發炎藥
• 疫苗
• 藥用飼料添加劑
• 其他

全球動物用藥品市場規模：依動物類型分類

• 伴侶動物
• 家畜
• 家禽
• 水產養殖

全球動物用藥品市場規模：依給藥途徑分類

• 口服
• 注射藥物
• 外用
• 其他

全球動物用藥品市場規模：依應用領域分類

• 細菌感染疾病
• 病毒感染疾病
• 寄生蟲病
• 疼痛管理
• 營養補充品
• 其他

全球動物用藥品市場規模：依分銷管道分類

• 獸醫醫院和診所
• 零售藥房
• 網路藥房
• 飼料商店和批發商

全球動物用藥品市場規模：依最終用戶分類

• 動物醫院
• 動物診所
• 畜牧場
• 寵物飼主

全球動物用藥品市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Zoetis
• Merck Animal Health
• Elanco Animal Health
• Boehringer Ingelheim Animal Health
• Ceva Sante Animale
• Virbac
• Dechra Pharmaceuticals
• Vetoquinol
• Phibro Animal Health
• IDEXX Laboratories
• HIPRA
• Neogen Corporation
• Bimeda
• Norbrook Laboratories
• Indian Immunologicals
• SeQuent Scientific
• Hester Biosciences
• Zydus Animal Health
• Kyoritsu Seiyaku Corporation
• Chanelle Pharma

結論與建議

Global Veterinary Drug Market size was valued at USD 47.5 Billion in 2024 and is poised to grow from USD 50.92 Billion in 2025 to USD 88.81 Billion by 2033, growing at a CAGR of 7.2% during the forecast period (2026-2033).

The global veterinary drug market is primarily driven by increasing demand for animal health products, influenced by rising pet ownership, enhanced livestock production, and heightened health awareness. This market includes pharmaceuticals, vaccines, parasiticides, and biologics essential for both companion and production animals, significantly impacting food security and zoonotic disease control. The evolution of targeted therapies and biologics, such as monoclonal antibodies, has transformed animal care. Antimicrobial resistance and stringent regulatory frameworks influence market dynamics, prompting alternative strategies like vaccines and probiotics. Moreover, advancements in AI are revolutionizing drug discovery by utilizing data-driven insights for target identification and drug optimization, ultimately shortening development timelines and enhancing translational relevance across species. This tech-driven shift presents new commercial opportunities within the veterinary sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Veterinary Drug market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Veterinary Drug Market Segments Analysis

Global veterinary drug market is segmented by product type, animal type, route of administration, application, distribution channel, end user and region. Based on product type, the market is segmented into Anti-Infectives, Parasiticides, Anti-Inflammatory Drugs, Vaccines, Medicated Feed Additives and Others. Based on animal type, the market is segmented into Companion Animals, Livestock Animals, Poultry and Aquaculture. Based on route of administration, the market is segmented into Oral, Injectable, Topical and Others. Based on application, the market is segmented into Bacterial Infections, Viral Infections, Parasitic Diseases, Pain Management, Nutritional Supplementation and Others. Based on distribution channel, the market is segmented into Veterinary Hospitals & Clinics, Retail Pharmacies, Online Pharmacies and Feed Stores & Distributors. Based on end user, the market is segmented into Veterinary Hospitals, Veterinary Clinics, Animal Farms and Pet Owners. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Veterinary Drug Market

One of the key market drivers for the Global Veterinary Drug Market is the increasing prevalence of zoonotic diseases and the rising awareness regarding animal health among pet owners and livestock farmers. The growth of the pet industry, along with a greater emphasis on preventive care, has significantly influenced the demand for veterinary medications. Additionally, advancements in veterinary pharmaceuticals, focusing on effective treatment options and safer formulations, further propel market expansion. As public health concerns regarding animal-origin diseases intensify, the necessity for innovative veterinary drugs becomes more critical, ultimately driving the market for enhanced animal healthcare solutions.

Restraints in the Global Veterinary Drug Market

One significant market restraint for the global veterinary drug market is the stringent regulatory environment governing the approval and use of pharmaceutical products for animals. Regulatory authorities require extensive research data, including clinical trials, to ensure the safety and efficacy of veterinary medications. This rigorous approval process can lead to increased development costs and extended timeframes for product launches, potentially discouraging innovation. Moreover, varying regulations across different regions can complicate the market landscape, making it challenging for companies to navigate compliance and impacting their ability to reach diverse markets effectively.

Market Trends of the Global Veterinary Drug Market

The Global Veterinary Drug market is witnessing a transformative shift driven by the adoption of digital diagnostics and telemedicine. Remote consultations and advanced point-of-care diagnostic tools are revolutionizing clinical workflows, allowing for swift decision-making and enhanced patient monitoring. AI-enabled technologies and cloud-based services are broadening access to veterinary care, extending beyond the confines of traditional clinics. The integration of these innovations with practice management systems is fostering new revenue streams and service models, raising the bar for convenience and responsiveness in veterinary services. Collaborations among manufacturers and service providers are becoming vital for creating comprehensive solutions, necessitating significant investment in clinician training and data interoperability.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape
• Value Chain Analysis
• Case Studies
• Technology Assessment
• Customer & Buying Criteria Analysis
• Pipeline Analysis
• Disease Epidemiology

Global Veterinary Drug Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Anti-Infectives
• Parasiticides
• Anti-Inflammatory Drugs
• Vaccines
• Medicated Feed Additives
• Others

Global Veterinary Drug Market Size by Animal Type & CAGR (2026-2033)

• Market Overview
• Companion Animals
• Livestock Animals
• Poultry
• Aquaculture

Global Veterinary Drug Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Oral
• Injectable
• Topical
• Others

Global Veterinary Drug Market Size by Application & CAGR (2026-2033)

• Market Overview
• Bacterial Infections
• Viral Infections
• Parasitic Diseases
• Pain Management
• Nutritional Supplementation
• Others

Global Veterinary Drug Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Veterinary Hospitals & Clinics
• Retail Pharmacies
• Online Pharmacies
• Feed Stores & Distributors

Global Veterinary Drug Market Size by End User & CAGR (2026-2033)

• Market Overview
• Veterinary Hospitals
• Veterinary Clinics
• Animal Farms
• Pet Owners

Global Veterinary Drug Market Size & CAGR (2026-2033)

• North America (Product Type, Animal Type, Route of Administration, Application, Distribution Channel, End User)
  • US
  • Canada
• Europe (Product Type, Animal Type, Route of Administration, Application, Distribution Channel, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Animal Type, Route of Administration, Application, Distribution Channel, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Animal Type, Route of Administration, Application, Distribution Channel, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Animal Type, Route of Administration, Application, Distribution Channel, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Zoetis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Sante Animale
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dechra Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetoquinol
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phibro Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IDEXX Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HIPRA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neogen Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bimeda
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Norbrook Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indian Immunologicals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SeQuent Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hester Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zydus Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kyoritsu Seiyaku Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chanelle Pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations